EP1765763A2 - Verfahren zur herstellung von optisch aktiven alkylbernsteinsäuremonoalkylestern - Google Patents
Verfahren zur herstellung von optisch aktiven alkylbernsteinsäuremonoalkylesternInfo
- Publication number
- EP1765763A2 EP1765763A2 EP05772382A EP05772382A EP1765763A2 EP 1765763 A2 EP1765763 A2 EP 1765763A2 EP 05772382 A EP05772382 A EP 05772382A EP 05772382 A EP05772382 A EP 05772382A EP 1765763 A2 EP1765763 A2 EP 1765763A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- alkyl
- optically active
- hydrogenation
- atoms
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/303—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by hydrogenation of unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Definitions
- the invention relates to a novel process for the preparation of optically active alkyl-succinic acid monoalkyl esters.
- R, R 1 alkyl, aryl, arylalkyl via an asymmetric hydrogenation starting from their directly unsaturated precursors has not yet been satisfactorily resolved.
- optical purity achieved in the processes cited does not therefore meet the requirements in the active substance range without additional enrichment steps, which in most cases require an enantiomeric excess of ⁇ 98% ee.
- D and E independently of one another, denote H, C 1 -C 10 -alkyl, RC 1 -C 10 -alkyl, aryl or alkylaryl,
- R 1 and R 2 independently of one another are C 1 -C 6 -alkyl, aryl, alkylaryl, R 1 furthermore hydrogen,
- B a bridge member with 1-5 C atoms between the two P atoms or Cp-Fe-Cp.
- the compounds of the formula (I) are optically active compounds which are each intended to represent an enantiomer (R or S).
- Enantioselective hydrogenation is to be understood below to mean that not both enantiomers are formed to the same extent by the hydrogenation, but that one enantiomer (R or S) in high optical purity, in particular with an ee value of 98, 99, 99.5 % is formed.
- Preferred starting compounds (II) are those in which D and E, independently of one another, have the meaning H, methyl, ethyl, propyl, butyl, pentyl, hexyl, tert-butyl, octyl, nonyl, decyl, the alkyl designation being both unbranched and the branched isomers. Particular preference is given to those starting compounds in which D and E are H and methyl, in particular those in which D and E are H or D and E are methyl. Further preferred starting compounds (II) are those in which D is H and E is butyl.
- the radical R can be C r Ci 0 - alkyl, in which individual H atoms of the alkyl radical in turn by further radicals such as OH, NH 2, NO 2, CN, F, Cl, Br, J, may be replaced.
- R can also be aryl radicals such as phenyl, naphthyl, and also alkylaryl radicals such as benzyl, where the aryl radicals can also be substituted again.
- the catalysts consist of a metal atom of the group Pd, Pt, Ru, Rh, Ni, Ir. Particularly preferred are catalysts with Rh, Ru or Ir as the metal atom, in particular Rh catalysts are suitable for the inventive method.
- precursors such as
- X can be any generally known anion in the asymmetric synthesis known to those skilled in the art.
- Examples of X are halogens such as Cl “ , Br “ , I “ , BF 4 -, CIO 4 -, SbF 6 -, PF 6 -, CF 3 SO 3 -, BAr 4 - preferred for X are BF 4 " , CF 3 SO 3 -, SbF 6 -, CIO 4 -, in particular BF 4 - and CF 3 SO 3 -.
- the catalysts of the process according to the invention contain one or more phosphoan ligands of the general formula (L).
- Preferred substituents R 1 and R 2 are H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, benzyl.
- radicals R 1 are preferred in which the two R 1 are bridged, such as isopropylidene or benzylidene.
- Preferred ligands L are those in which A represents a further phospholane residue together with a bridging member B, where B is a bridge of 1 to 5 C atoms.
- Atoms between the two phosphorus atoms does not mean that B consists of a maximum of 5 C atoms, but that the direct connection between the two P atoms does not comprise more than 5 C atoms.
- B may be a phenyl ring if the two P atoms are ortho attached to it.
- bridging compound B may also be a ferrocene-type compound consisting of substituted or unsubstituted cyclopentadienyl radicals (Cp) sandwiching an Fe atom (Cp-Fe-Cp), the P atoms being attached to the Cp radicals ,
- Particularly preferred ligands L are:
- Ligand MetaU Complexes can be prepared by using in a known manner ⁇ eg Uson, Inorg. Chim. Acta 73, 275 1983, EP-A 0158875, EP-A 437690) by reaction with rhodium, iridium, ruthenium, palladium, platinum; Nickel complexes containing labile ligands (eg, [RuCI 2 (COD) J n , [Rh (COD) 2 ] BF 4 , [Rh (COD) 2 ] CF 3 SO 3 Rh (COD) 2 CIO 4 , [Ir (COD) CI] 2 , p-cymene-ruthenium chloride dimer) catalytically active complexes synthesized.
- labile ligands eg, [RuCI 2 (COD) J n , [Rh (COD) 2 ] BF 4 , [Rh (COD) 2 ] CF 3 SO 3 Rh (COD) 2 CIO
- NBD can also be used successfully for the preparation of the complexes.
- Suitable solvents are all solvents known to those skilled in the art for asymmetric hydrogenation.
- Preferred solvents are lower alkyl alcohols such as methanol, ethanol, isopropanol, and toluene, THF 1 ethyl acetate. Particular preference is given to using methanol as solvent in the process according to the invention.
- the inventive hydrogenation is generally carried out at a temperature of -20 to 15O 0 C, preferably at 0 to 100 0 C and particularly preferably at 10 - leads 8O 0 C Oberge.
- the hydrogenation according to the invention uses substrate / catalyst ratios s / c ⁇ 20 000/1 and thereby gives ⁇ 98% ee. Even with s / c 110 000/1 an ee of 98% is achieved.
- the catalyst consumption can be lowered even further.
- the hydrogen pressure can be varied within a wide range between 0.1 bar and 300 bar for the hydrogenation process according to the invention. Very good results are obtained in a pressure range of 1 to 200 bar, preferably 1 to 100 bar.
- the work-up of the reaction mixture is carried out by methods known to those skilled in the art.
- the product may e.g. converted into a carboxylate, precipitated and so separated from the catalyst and then released again, alternatively, the catalyst can also be adsorbed on a bed, which allows easy to carry out chromatographic purification. A distillative removal of the product from the catalyst is also possible.
- the enantiomeric excess of the product (2f?) - methyl succinic acid 4-monomethyl ester was determined by gas chromatography to> 98% (company: BGB analysis, column type: BGB-174, length: 30 m, inner diameter: 0.25 ml, film thickness: 0, 25 microns, carrier gas: helium, pressure: 2.35 bar, temperature: 135 0 C, heating rate: 1.2 ° C / min, retention time R-enantiomer: 23.3 min, retention time S-enantiomer: 22.6 min).
- the s / c ratio was 20,000: 1.
- Example 3 The reaction described in Example 1 was carried out with a catalyst / substrate ratio s / c of 40000/1. After 4 hours, the substrate was completely reacted. The enantiomeric excess of the product was> 98%.
- Example 3 The reaction described in Example 1 was carried out with a catalyst / substrate ratio s / c of 40000/1. After 4 hours, the substrate was completely reacted. The enantiomeric excess of the product was> 98%.
- the mixture was then hydrogenated at 6O 0 C and 5 bar hydrogen. After 16 h, the starting material was completely reacted. The enantiomeric excess of the product was 98%.
- Rophos A bistriflate salt (Rophos * 2 CF 3 SO 3 H) is treated with 1.1 eq.
- Amount of base preferably amines such as triethylamine, Hünigbase or similar
- the metal source preferably (Rh [COD] 2 )
- X BF 4 , CF 3 SO 3 , SbF 6 , PF 6 , CIO 4 , BAr 4
- the mixture is allowed to come to room temperature.
- the free ligand is used, the base addition is omitted.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200410032968 DE102004032968A1 (de) | 2004-07-07 | 2004-07-07 | Verfahren zur Herstellung von optisch aktiven Alkylbernsteinsäuremonoalkylestern |
DE200510007750 DE102005007750A1 (de) | 2005-02-18 | 2005-02-18 | Verfahren zur Herstellung von optisch aktiven Alkylbernsteinsäuremonoalkylestern |
PCT/EP2005/007289 WO2006002999A2 (de) | 2004-07-07 | 2005-07-06 | Verfahren zur herstellung von optisch aktiven alkylbernsteinsäuremonoalkylestern |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1765763A2 true EP1765763A2 (de) | 2007-03-28 |
Family
ID=35431129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05772382A Withdrawn EP1765763A2 (de) | 2004-07-07 | 2005-07-06 | Verfahren zur herstellung von optisch aktiven alkylbernsteinsäuremonoalkylestern |
Country Status (4)
Country | Link |
---|---|
US (1) | US7557240B2 (de) |
EP (1) | EP1765763A2 (de) |
JP (1) | JP2008505152A (de) |
WO (1) | WO2006002999A2 (de) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0158875B1 (de) | 1984-04-19 | 1989-12-13 | F. Hoffmann-La Roche Ag | Chirale Rhodium-diphosphinkomplexe für asymmetrische Hydrierungen |
DE4001019A1 (de) | 1990-01-16 | 1991-07-18 | Degussa | Verfahren zur asymmetrischen hydrierung von (alpha)-ketocarbonylverbindungen zu optisch aktiven (alpha)-hydroxycarbonylverbindungen |
DE19725796A1 (de) * | 1997-06-18 | 1998-12-24 | Basf Ag | Herstellung optisch aktiver Phospholane, deren Metallkomplexe und Anwendung in der asymmetrischen Synthese |
GB9823716D0 (en) * | 1998-10-29 | 1998-12-23 | Isis Innovation | Diphosphines |
CA2347146A1 (en) | 1998-11-05 | 2000-05-18 | Chirotech Technology Limited | Chiral ligands for asymmetric catalysis |
-
2005
- 2005-07-06 US US11/571,725 patent/US7557240B2/en not_active Expired - Fee Related
- 2005-07-06 EP EP05772382A patent/EP1765763A2/de not_active Withdrawn
- 2005-07-06 WO PCT/EP2005/007289 patent/WO2006002999A2/de active Application Filing
- 2005-07-06 JP JP2007519713A patent/JP2008505152A/ja active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO2006002999A3 * |
Also Published As
Publication number | Publication date |
---|---|
US7557240B2 (en) | 2009-07-07 |
WO2006002999A2 (de) | 2006-01-12 |
WO2006002999A3 (de) | 2006-09-08 |
US20080058547A1 (en) | 2008-03-06 |
JP2008505152A (ja) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT339287B (de) | Verfahren zur herstellung von optisch aktiven alfa-n-acylamino-propionsauren | |
DE2161200C3 (de) | Optisch aktive, zweibindige Liganden, katalytische Komposition, die diese Liganden enthält, sowie Verfahren zur asymetrischen Hydrierung von Kohlenstoff-Kohlenstoff-Doppelbindungen unter Anwendung dieser katalytischen Komposition | |
EP2139835A1 (de) | Verfahren zur herstellung optisch aktiver carbonylverbindungen | |
DE60313357T2 (de) | Verfahren zur katalytischen hydrierung von kohlenstoff-heteroatom-doppelbindungen | |
EP0780157B1 (de) | Rutheniumkomplexe mit einem chiralen, zweizähnigen Phosphinoxazolin-Liganden zur enantioselektiven Transferhydrierung von prochiralen Ketonen | |
EP0965574B1 (de) | Verfahren zur enantioselektiven Hydrierung | |
DE69921588T2 (de) | Aminophosphin-Metallkomplex für asymmetrische Reaktionen | |
DE112015001290T5 (de) | Verfahren zur Herstellung optisch aktiver Verbindungen | |
DE602004008478T2 (de) | Biphosphinrutheniumkomplexe mit chiralen diaminliganden als katalysatoren | |
EP1760055A2 (de) | Eisen-katalysierte allylische Alkylierung | |
EP1200452B1 (de) | Neue chirale phosphorliganden und ihre verwendung in der herstellung optisch aktiver produkte | |
DE3008671A1 (de) | Verfahren zur katalytischen umwandlung von carbonylverbindungen bzw. hydroxylverbindungen | |
DE19647892A1 (de) | Verfahren zur katalytischen, enantioselektiven Reduktion von Ketonen | |
WO2006002999A2 (de) | Verfahren zur herstellung von optisch aktiven alkylbernsteinsäuremonoalkylestern | |
DE60020775T2 (de) | Stereospezifische Isomerierung von Allylaminen unter Verwendung von immobiliserten chiralen Phospho-Liganden | |
DE102005007750A1 (de) | Verfahren zur Herstellung von optisch aktiven Alkylbernsteinsäuremonoalkylestern | |
DE102004032968A1 (de) | Verfahren zur Herstellung von optisch aktiven Alkylbernsteinsäuremonoalkylestern | |
EP1885732B1 (de) | CHIRALE DIPHOSPHONITE ALS LIGANDEN IN DER RUTHENIUM-KATALYSIERTEN ENANTIOSELEKTIVEN REDUKTION VON KETONEN, ß-KETOESTERN UND KETIMINEN | |
AT501193B1 (de) | Verfahen zur übergangsmetall - katalysierten asymmetrischen hydrierung von acrylsäurederivaten | |
DE2908358A1 (de) | Optisch aktive tertiaere phosphinoxide und tertiaere phosphine, verfahren zu deren herstellung und verwendung der optisch aktiven tertiaeren phosphine fuer asymmetrische synthesen | |
CH635815A5 (en) | Process for preparing optically active alpha-hydroxycarboxylic esters | |
DE69914889T2 (de) | Asymmetrische hydrierung | |
DE69913412T2 (de) | Stereospezifische Isomerisierung von Allylaminen unter Verwendung von Chiralen Phospho-Liganden | |
DD253995A1 (de) | Verfahren zur herstellung von (r)- und (s)-phenyl-alanin und dessen derivaten | |
EP1409493A1 (de) | Verfahren zur herstellung von nicht-chiralen und optisch aktiven hydroxygruppen enthaltenden organischen verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
17P | Request for examination filed |
Effective date: 20070308 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BASF SE |
|
17Q | First examination report despatched |
Effective date: 20121122 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20150203 |